1. Home
  2. WLFC vs RLAY Comparison

WLFC vs RLAY Comparison

Compare WLFC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willis Lease Finance Corporation

WLFC

Willis Lease Finance Corporation

HOLD

Current Price

$120.20

Market Cap

1.0B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.82

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLFC
RLAY
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
WLFC
RLAY
Price
$120.20
$7.82
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$16.00
AVG Volume (30 Days)
57.4K
2.3M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
1.30%
N/A
EPS Growth
17.99
N/A
EPS
16.70
N/A
Revenue
$674,381,000.00
$8,355,000.00
Revenue This Year
$16.17
$27.30
Revenue Next Year
$4.88
$7.43
P/E Ratio
$7.35
N/A
Revenue Growth
29.58
N/A
52 Week Low
$114.01
$1.78
52 Week High
$229.67
$8.36

Technical Indicators

Market Signals
Indicator
WLFC
RLAY
Relative Strength Index (RSI) 45.62 64.31
Support Level $114.01 $6.28
Resistance Level $135.00 $8.36
Average True Range (ATR) 5.23 0.50
MACD 0.20 0.14
Stochastic Oscillator 37.38 76.56

Price Performance

Historical Comparison
WLFC
RLAY

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: